Investment Summary

Eight Roads Invests In b-ONE Ortho

On September 26, 2018, private equity firm Eight Roads invested in medical products company b-ONE Ortho

Investment Highlights
  • This is Eight Roads’ 9th transaction in the Medical Products sector.
  • This is Eight Roads’ 92nd transaction in the United States.
  • This is Eight Roads’ 3rd transaction in New Jersey.

Investment Summary
Date 2018-09-26
Target b-ONE Ortho
Sector Medical Products
Investor(s) Eight Roads
Deal Type Venture

Target

b-ONE Ortho

Cedar Knolls, New Jersey, United States
b-ONE Ortho develops orthopedic healthcare solutions. The company’s product includes B-One total hip system which features coating technology and instrumentation. b-ONE Ortho was founded in 2015 and is based in Cedar Knolls, New Jersey.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Eight Roads

Investor

Category Private Equity Firm
Founded 1969
Size Small
Type Sector Focused
DESCRIPTION

Eight Roads is a private investment firm focused on a variety of investment opportunities across the US, Europe, and Asia. The Firm is divided into several investment strategies including venture, principal investing, and real estate. Within the principal investments group, Eight Roads backs established growth businesses with long-term capital. Eight Roads does not have any sector preferences, but has experience in fintech, business services, and healthcare. Eight Roads is based in London.

DEAL STATS #
Overall 199 of 298
Sector (Medical Products) 9 of 15
Type (Venture) 175 of 269
State (New Jersey) 3 of 4
Country (United States) 92 of 124
Year (2018) 23 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-23 Payke

Okinawa, Japan

Payke is an application that allows to view all the information of products in their mother tongue. The application "Payke" makes it possible to connect products around the world to the Internet by utilizing the bar codes that are scattered throughout the world. Payke was founded in 2014 and is based in Okinawa, Japan.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-01 Modis Therapeutics

Oakland, California, United States

Modis Therapeutics is a biopharmaceutical company focused on developing disease-modifying therapies for rare genetic diseases with a high unmet medical need. Modis program (MT1621) is in clinical development for TK2d, an inherited mitochondrial disease. Modis Therapeutics was founded in 2016 and is headquartered in Oakland, California, with offices in New York City.

Buy -
Mergr

Product

Company

Legal